Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

ORMPORMP
10 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in ORAMED PHARMACEUTICALS INC

Connor, Clark & Lunn Investment Management Ltd. holds 50,207 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $170,704 as of 2026-Q1. The position was increased (+14.8% shares). ORMP represents 0.0% of Connor, Clark & Lunn Investment Management Ltd.'s portfolio.

Current Value

$170,704

Current Shares

50,207

Total Value Change

-$397,296

Total Shares Change

+24,353

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
50,207
+14.8%
$170,7040.0%$3.38
26
2025-Q4
Increased
43,735
+54.9%
$124,6450.0%$2.62
31
2025-Q3
Decreased
28,243
-53.3%
$74,5620.0%$2.52
0
2025-Q2
Decreased
60,449
-30.6%
$136,0100.0%$2.00
0
2025-Q1
Decreased
87,136
-18.6%
$186,4710.0%$2.06
0
2024-Q4
Decreased
107,062
-4.0%
$259,0900.0%$2.17
0
2024-Q3
New
111,519
-
$272,1060.0%$2.31
32
2022-Q1
Exited
0
-100.0%
$00.0%$8.41
0
2021-Q4
Increased
50,786
+96.4%
$725,0000.0%$12.79
39
2021-Q3
New
25,854
-
$568,0000.0%$20.83
34

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used